Skip to content
Biodatica
Start free

Investigator

Lianghui Zhang

UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NHLBI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Mar 15, 2021

Latest Aug 10, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

  • Akeso

    OncologyPhase IIListed · 9926.HK

    68momentum

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Pathogenic mechanisms of chronic lung sequelae following respiratory viral infection

    $755k

    Aug 10, 2025NHLBIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11224791 (opens the source filing in a new tab)

  2. R01

    Pathogenic Mechanism and Therapeutic Approaches for Exercise Intolerance in Post-Acute Sequelae of COVID-19

    $633k

    Apr 1, 2025NHLBIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11019369 (opens the source filing in a new tab)

  3. R01

    Endothelial antigen presentation to T cells as a pathogenic mechanism in influenza-induced acute lung injury

    $398k

    Mar 15, 2021NHLBIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11037964 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources